GlassScriptPhysician profile
Sharon Curtin
NPI 1003118852
$722.25
in general payments reported to CMS, 2019-2025
13 companies · $227 in 2025
The $227 reported for 2025 was less than what a typical Psychiatric/Mental Health, Child & Adolescent (Clinical Nurse Specialist) provider received nationally (typical 2025 total: $315).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $59.58 · 2022: $81.76 · 2023: $121 · 2024: $233 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $167.33 | 2021-2025 | Qelbree |
| Abbvie INC. | $114.18 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $83.10 | 2024-2025 | Rexulti |
| Alkermes, INC. | $53.82 | 2023-2025 | Aristada, Lybalvi |
| Sunovion Pharmaceuticals INC. | $53.58 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.47 | 2022-2023 | Trintellix |
| Neurocrine Biosciences, INC. | $45.62 | 2022-2024 | Ingrezza |
| Collegium Pharmaceutical, INC. | $39.67 | 2025 | Jornay Pm |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $31.07 | 2025 | Caplyta |
| Axsome Therapeutics, INC. | $27.47 | 2024 | Auvelity |
| E.R. Squibb & Sons, L.L.C. | $20.86 | 2025 | Cobenfy |
| Corium, LLC | $20.35 | 2024 | Azstarys |
| Tempus Ai, INC | $14.73 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Curtin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.